Literature DB >> 9195933

Sphingosylphosphocholine reduces the calcium ion requirement for activating tissue transglutaminase.

T S Lai1, A Bielawska, K A Peoples, Y A Hannun, C S Greenberg.   

Abstract

Tissue transglutaminase (tTG) catalyzes a Ca2+-dependent transglutaminase reaction resulting in the formation of gamma-glutamyl-epsilon-lysine bonds and is activated during apoptosis to catalyze the formation of apoptotic body. We investigate whether lipids that are membrane components and involved in cell signaling could modify the Ca2+-dependent activation of tTG. We found that sphingosylphosphocholine (lyso-SM) was the only lipid to activate transglutaminase at low Ca2+ concentrations. In the presence of lyso-SM (125 microM), transglutaminase was detectable at 10 microM Ca2+, whereas in the absence of lyso-SM, similar activity was obtained at 160 microM Ca2+. Furthermore, in the presence of lipid vesicles lyso-SM retained the ability to enhance the Ca2+-dependent activation of tTG. Lyso-SM did not significantly change the Km for the glutamyl and primary amine substrates. However, the Kact for Ca2+ was reduced from 300 microM to 90 microM. Structure-function studies of lyso-SM analogs indicate that phosphocholine group on C1, the free amino group at C2 and a C4-C5 double bond are critical for the activation of transglutaminase activity. This is the first demonstration that a specific sphingolipid could enhance the activity of tTG and could play a role in vivo in activation of the tTG at physiologic Ca2+ levels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9195933     DOI: 10.1074/jbc.272.26.16295

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  Roles of transglutaminases in cardiac and vascular diseases.

Authors:  David C Sane; Jimmy L Kontos; Charles S Greenberg
Journal:  Front Biosci       Date:  2007-01-01

Review 2.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

3.  The Differential Effects of R580A Mutation on Transamidation and GTP Binding Activity of Rat and Human Type 2 Transglutaminase.

Authors:  Qingmin Ruan; Janusz Tucholski; Soner Gundemir; Gail V W Johnson Voll
Journal:  Int J Clin Exp Med       Date:  2008-06-30

4.  Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis.

Authors:  Sunando Datta; Marc A Antonyak; Richard A Cerione
Journal:  Biochemistry       Date:  2006-11-07       Impact factor: 3.162

Review 5.  Transglutaminases: nature's biological glues.

Authors:  Martin Griffin; Rita Casadio; Carlo M Bergamini
Journal:  Biochem J       Date:  2002-12-01       Impact factor: 3.857

6.  Type 2 transglutaminase is involved in the autophagy-dependent clearance of ubiquitinated proteins.

Authors:  M D'Eletto; M G Farrace; F Rossin; F Strappazzon; G Di Giacomo; F Cecconi; G Melino; S Sepe; S Moreno; G M Fimia; L Falasca; R Nardacci; M Piacentini
Journal:  Cell Death Differ       Date:  2012-02-10       Impact factor: 15.828

Review 7.  Type 2 transglutaminase in Huntington's disease: a double-edged sword with clinical potential.

Authors:  P G Mastroberardino; M Piacentini
Journal:  J Intern Med       Date:  2010-11       Impact factor: 8.989

8.  Phosphorylation of transglutaminase 2 (TG2) at serine-216 has a role in TG2 mediated activation of nuclear factor-kappa B and in the downregulation of PTEN.

Authors:  Yi Wang; Sudharsana R Ande; Suresh Mishra
Journal:  BMC Cancer       Date:  2012-07-03       Impact factor: 4.430

9.  Inhibition of cytokinesis by a lipid metabolite, psychosine.

Authors:  T Kanazawa; S Nakamura; M Momoi; T Yamaji; H Takematsu; H Yano; H Sabe; A Yamamoto; T Kawasaki; Y Kozutsumi
Journal:  J Cell Biol       Date:  2000-05-15       Impact factor: 10.539

Review 10.  Strategies towards in vivo imaging of active transglutaminase type 2 using positron emission tomography.

Authors:  Berend van der Wildt; Adriaan A Lammertsma; Benjamin Drukarch; Albert D Windhorst
Journal:  Amino Acids       Date:  2016-07-05       Impact factor: 3.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.